Therapeutic drug monitoring of cyclosporine microemulsion in interstitial pneumonia with dermatomyositis

Modern Rheumatology

Volumn 21, Issue 1, 2011, Pages 32-36

  Nagai, Koji ^a   Takeuchi, Tohru ^a   Kotani, Takuya ^a   Hata, Kenichiro ^a   Yoshida, Shuzo ^a   Isoda, Kentaro ^a   Fujiki, Youhei ^a   Shiba, Hideyuki ^a   Makino, Shigeki ^a   Hanafusa, Toshiaki ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Cyclosporine; Dermatomyositis; Interstitial pneumonia; Monitoring

Indexed keywords

CYCLOSPORIN; PREDNISOLONE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DERMATOMYOSITIS; DISEASE ASSOCIATION; DOSAGE SCHEDULE COMPARISON; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MONITORING; EVENING DOSAGE; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; MALE; MICROEMULSION; MORNING DOSAGE; PNEUMOMEDIASTINUM; POSTPRANDIAL STATE; PRIORITY JOURNAL; SINGLE DRUG DOSE; STOMACH CANCER;

AGED; ANTIRHEUMATIC AGENTS; AREA UNDER CURVE; CYCLOSPORINE; DERMATOMYOSITIS; DRUG MONITORING; DRUG THERAPY, COMBINATION; EMULSIONS; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PREDNISONE;

EID: 79951946493     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-010-0342-2     Document Type: Article

References (15)

1. M Hirakata S Nagai 2000 Interstitial lung disease in polymyositis and dermatomyositis Curr Opin Rheumatol 12 501 508 1:STN:280:DC%2BD3M3osVCjtw%3D%3D 10.1097/00002281-200011000-00005 11092199
2. K Nagasaka M Harigai M Tateishi M Hara Y Yoshizawa T Koike, et al. 2003 Efficacy of combination treatment with cyclosporin A and corticosteroids for acute interstitial pneumonitis associated with dermatomyositis Mod Rheumatol 13 231 238 1:CAS:528:DC%2BD3sXntlShurc%3D 10.1007/s10165-003-0205-1 (Pubitemid 37258791)
3. H Kuroda H Morinaga C Satoh A Miyake K Sunami 2003 Clinical study of 10 cases of acute or subacute interstitial pneumonia associated with dermatomyositis Mod Rheumatol 13 313 318 10.1007/s10165-003-0251-8 (Pubitemid 38208386)
4. T Kotani S Makino T Takeuchi M Kagitani T Shoda A Hata, et al. 2008 Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis J Rheumatol 35 254 259 1:CAS:528: DC%2BD1cXjtFamtr0%3D 18085732 (Pubitemid 351284439)
5. K Mahalati P Belitsky I Sketris K West R Panek 1999 Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation Transplantation 68 55 62 1:STN:280:DyaK1MzlsFahsw%3D%3D 10.1097/00007890-199907150-00011 10428267 (Pubitemid 29352830)
6. F Akhlaghi L Gonzalez AK Trull 2005 Association between cyclosporine concentrations at 2 hours post-dose and clinical outcomes in de novo lung transplant recipients J Heart Lung Transplant 24 2120 2128 10.1016/j.healun. 2005.05.005 16364860 (Pubitemid 41814735)
7. G Levy E Thervet J Lake K Uchida Consensus on Neoral C(2): Expert Review in Transplantation (CONCERT) Group 2002 Patient management by Neoral C(2) monitoring: an international consensus statement Transplantation 73 S12 S18 10.1097/00007890-200205151-00003 12023608
8. H Takizawa J Shiga Y Moroi S Miyachi M Nishiwaki T Miyamoto 1987 Interstitial lung disease in dermatomyositis: clinicopathological study J Rheumatol 14 102 107 1:STN:280:DyaL2s7pvVGjsg%3D%3D 3494844 (Pubitemid 17054776)
9. Y Umezawa A Ozawa 2007 Optimal time for therapeutic drug monitoring of cyclosporine microemulsion in patients with psoriasis Int J Dermatol 46 763 766 1:CAS:528:DC%2BD2sXpsFKgurg%3D 10.1111/j.1365-4632.2007.03136.x 17614813 (Pubitemid 47046202)
10. M Naito T Takei A Eguchi K Uchida K Tsuchiya K Nitta 2008 Monitoring of blood cyclosporine concentration in steroid-resistant nephrotic syndrome Intern Med 47 1567 1572 10.2169/internalmedicine.47.1088 18797114
11. Y Yamasaki H Yamada M Yamasaki M Ohkubo K Azuma S Matsuoka, et al. 2007 Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis Rheumatology (Oxford) 46 124 130 1:CAS:528:DC%2BD28XhtlChtbnE 10.1093/rheumatology/kel112 (Pubitemid 44932799)
12. K Uchida Y Tominaga T Haba A Katayama T Sato S Matsuoka, et al. 2001 Usefulness of two-point AUC(0-4) monitoring in maintenance renal transplant patients Transplant Proc 33 3128 3130 1:CAS:528:DC%2BD3MXpt1alu7g%3D 10.1016/S0041-1345(01)02334-X 11750345 (Pubitemid 34042513)
13. DI Min PJ Perry HY Chen LG Hunsicker 1998 Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantation Pharmacotherapy 18 282 287 1:STN:280:DyaK1c3gsVOjug%3D%3D 9545147 (Pubitemid 28145144)
14. M Bunke R Sloan M Brier B Ganzel 1995 An improved glomerular filtration rate in cardiac transplant recipients with once-a-day cyclosporine dosing Transplantation 59 537 540 1:STN:280:DyaK2M7osVehtQ%3D%3D 7878758
15. T Kusaba Y Kono S Hatta T Fujino T Yasuda H Miura, et al. 2005 More stable and reliable pharmacokinetics with preprandial administration of cyclosporine compared with postprandial administration in patients with refractory nephrotic syndrome Pharmacotherapy 25 52 58 1:CAS:528: DC%2BD2MXltlOnu7k%3D 10.1592/phco.25.1.52.55617 15767220 (Pubitemid 40054033)